Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |